News
Computational Bio & Chem
Showing 1–21 of 21
Q&A
Ascend partners with industry to drive down gene therapy cost for better patient access
News
Radionetics announces $52.5 million Series A round co-led by DCVC Bio
Deep Tech Opportunities Report
Cryptography for the real world
Deep Tech Opportunities Report
The Engineered Patient
News
MycoWorks expands to address the soaring need for high-end leather alternatives
News
With Assets from Federation Bio, Kanvas Aims to Replace Imprecise Microbiome Therapies with a Single, Rationally Designed Pill
News
DCVC Leads $14 Million Seed Round for Noetik
Deep Tech Opportunities Report
Predictive drug development: toward efficacy from the get-go
News
DCVC leads $12M financing for Kanvas Biosciences to map the human body’s undiscovered territory: the microbiome
News
DCVC leads $13 million seed funding for ShennonBio—revolutionizing immunotherapy through immune cell profiling at unprecedented accuracy, speed
DCVC Announcements
DCVC Welcomes 2022
News
Biology-as-a-Platform in the Fight Against Cancer: Freenome Raises $270m Series C
DCVC Announcements
2021 and Deep Tech: Reasons for Optimism
Thoughts
Using Biology-as-a-Platform to Move from Treatment to Cure
News
Life sciences and Deep Tech: The next set of solutions to the next set of problems
Thoughts
An Update on How Deep Tech is Arming the Fight Against COVID-19
Thoughts
Powering a Comprehensive Response to the COVID-19 Crisis Through Deep Tech
News
Reimagining biologics: AbCellera and Novartis partner to find new disease treatments
News
AbCellera Raises $10M Series A: Deep Search for the Immune System
News